Skip to main content
. 2021 Jul 13;2(8):100212. doi: 10.1016/j.jtocrr.2021.100212

Table 1.

Testing Sites, Platforms Used, and Study Phase Participation

Laboratory # Platform Used Assays Phase 1 Phase 2 cfDNA Extraction Kit Used
1 Droplet digital PCR Bio-Rad EGFR assay and IDT (Integrated DNA Techonologies) designed primers and probes X X QIAamp circulating nucleic acid kit
2 NGS (S5) ThermoFisher Oncomine Lung cfDNA assay X X QIAamp circulating nucleic acid kit
3 NGS IlluminaTruSight Tumor 15 - TST15 panel X X QIAamp circulating nucleic acid kit
4 Real-time PCR (Cobas 4800) Cobas EGFR mutation test v2 X X Cobas cfDNA sample preparation kit
5 Real-time PCR Entrogen ctEGFR mutation detection kit X X Nucleosnap kit for plasma DNA
6 Real-time PCR Entrogen ctEGFR mutation detection kit X X QIAamp circulating nucleic acid kit
7 Real-time PCR (Cobas 4800) Cobas EGFR Mutation test v2 X X Cobas cfDNA sample preparation kit
8 Real-time PCR (Cobas 4800) Cobas EGFR mutation test v2 X Cobas cfDNA sample preparation kit
9 Mass array UltraSEEK lung panel X QIAamp circulating nucleic acid kit
Reference laboratory Droplet digital PCR Bio-Rad EGFR assay and IDT designed primers and probes X (1b only) X QIAamp circulating nucleic acid kit

#, number; cfDNA, cell-free DNA; IDT, integrated DNA Technologies; NGS, next-generation sequencing; PCR, polymerase chain reaction.